Research grants/Industry funded researchNext Generation ProgramSkoltech Biomedical InitiativeSkoltech Translational and Research Innovation Program – STRIPUMNIKHorizon 2020Systems biology fellowship
Study of organisation of neuronal response mechanisms in primates, rodents and invertebrates brain
Development of an oilseed expedited selection technology based on high-throughput methods for genotyping and molecular phenotyping to ensure food security of the Russian Federation.
Novel long non-coding RNAs as potential biomarkers for diagnostics of liver cancer
Big Neuro Data processing infrastructure to support new NeuroNet markets development (CoBrain).
Development of the technology of genetic evaluation of breeding pigs for economic-useful traits based on the methods of gene and genomic analysis and high-precision mass spectrometry to ensure the competitiveness of domestic breeding pig
Conducting tests of 10 promising hybrids of different soybean varieties. Getting full-genomic data
Technological platform for parallel structural study of individual molecules in natural organic matrices.
Analytical review of publicly available information on the potential use of phosphorus-mobilizing microorganisms to increase the fertility of soils
Engineering thermophage particles for studying virus assembly
Identification of Key genetic/epigenetic Marker(s) in cervical carcinogenesis and development of corresponding Molecular Therapeutics for precision medicine of cervical cancer
Systems biology fellowship program
Obtaining and biochemical characterization of Cas9 protein with CJSC
Relationship between interference and adaptation during the action of Type I-E CRISPR-Cas system of Escherichia coli
Computational approach for discovery of new CRISPR-Cas associated proteins
Study of the mechanisms of foreign DNA recognition by bacterial defense system BREX from Escherichi coli HS
Delivery of New Nucleases by AAV for Gene Therapy of Hereditary Diseases
Study of the regulation of expression of the genes of the restriction-modification Kpn2I system
Validation of a novel target for therapy - under NDA agreement
lncRNA LL35 as a regulator of Foxa 2 expression in vitro and in vivo - a probable target for diagnostics and therapeutics
Identification and functional validation of cancer-specific splicing changes caused by somatic mutations in structural pre-mRNA elements
Mass spectrometry studies of brain tissues affected by gliomas in order to create rapid methods of intraoperative identification of gliomas and determining the boundaries of the tumor during surgery
Next Generation Program (Skoltech — MIT Joint Projects) covers the whole range of academic and institution development activities. That includes research, education, innovation and academic services towards establishing and promoting a mutually beneficial longterm bilateral collaboration between Skoltech and MIT, as well as further development of Skoltech work streams.

3d-Printed, Miniaturized Cassinian Trap Mass Spectrometer for Space Research and General Ambient Analysis Applications
Regulation of Antitumor Response via Modulation of Ubr‐Ubiquitin Ligases In Vivo
Search and Development of New Genome Editing Tools for Biomedicine and Biotechnology
The Skoltech Biomedical Initiative (SBI) is an interdisciplinary cross-CREI program designed to get ready for collaboration with the Moscow International Medical Cluster at Skolkovo. The SBI is intended to nucleate new projects and to integrate them into a focused cross-CREI program that will refine and solidify Skoltech’s mission in biomedical relevant areas of research, education and innovation.

Magnetic nanoparticles and carbon nanotubes as enhancers for targeted RNA delivery in vivo
Personalized bacteriophage therapy of clostridium Difficile Infections
Machine learning and pattern recognition for the development of diagnostic and clinical prognostic prediction tools in psychiatry line mental disorders and neurology
Deciphering the cause of human pregancy lose by exome analysis of abortuses



Skoltech Translational and Research Innovation Program awards one year of funding  for translational research to bridge the gap between laboratory and marketplace and drives innovation and entrepreneurship in Russia. The Program provides critical support for participating teams to help establish proof of concept and provide assistance with advancing their technology towards commercialization, including pre-start up identification of high potential market opportunities, intellectual property management, and, if appropriate, team development. It helps to ensure that the invention meets the market technological requirements and finds its niche. It is developed in collaboration with the Deshpande Center for Technological Innovation at the Massachusetts Institute of Technology (MIT). Both The Deshpande Center and MIT have a proven track record of success in technology commercialisation.

Metagenomic approach for oil and gas industry
Targeted delivery of modified RNAs to the liver – an alternative Hepatitis C therapeutics
Development of Personal Genetic Screening System
A Platform Approach to Develop New Antibiotic Leads Based on Microcins

Foundation of Assistance to Small Innovative Enterprises (Bortnik’s foundation) is a non-profit organization set up by the Russian Government in 1994, formed in accordance with the Decree of the Government. The Foundation is classified as one of Russia’s most important scientific development institutions. UMNIK is the pre-seed funding program aimed to support young individual scientists by providing 500 000 rubles as nonrefundable nontaxable grant through multi-staged selection; selection of the winners is carried out in accredited institute by the expert panel (scientists and experts, business representatives, foundation representatives) prepared by Skoltech and approved by the Foundation.

Main objectives of the program:
– Provide state support for young scientists who want to fulfill their potential through innovation, and encouraging participation of young people in science, technology and innovation;
– Conduct research by young scientists in order to implement their results in the economy;
– Preparing young scientists for creation of small innovative enterprises, necessary for the application of research results.

UMNIK awards:


Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative aimed at securing Europe’s global competitiveness. Seen as a means to drive economic growth and create jobs, Horizon 2020 has the political backing of Europe’s leaders and the Members of the European Parliament. They agreed that research is an investment in our future and so put it at the heart of the EU’s blueprint for smart, sustainable and inclusive growth and jobs. By coupling research and innovation, Horizon 2020 is helping to achieve this with its emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.

By consortium agreement a first European network of FT-ICR (Fourier Transform Ion Cyclotron Resonance) mass spectrometry (MS) centers in association with a manufacturer and a SME software company was established.
Mass spectrometry (MS) has become the most ubiquitous analytical techniques in use today, providing more information on the composition and the structure of a substance from a smaller amount of sample than any other techniques.  FT-ICR MS is the most powerful MS technique. It offers up to 100 fold higher mass resolving power and mass accuracy than any other MS technique.
The EU_FT-ICR_MS network includes 10 FT-ICR MS centers from 8 different European countries (Belgium, Czech Republic, Finland, France, Germany, Italy, Portugal, and United Kingdom) and 1 third country (Russia), a European FT-ICR MS manufacturer and 2 SMEs. It includes centers equipped with up-to-date FT-ICR MS and expertise which will cover most of the field in which FT-ICR mass spectrometry is involved: BioOrganic & BioInorganic, Cultural heritage, Glycomics, Environment, Imaging, InfraRed Spectroscopy of Ions in the Gas Phase, Lipidomics, Medicine, Petroleum & Coal Oil, Nanoparticles, Organic chemistry, Physical chemistry, Proteomics, Structural biology.
The Project has 4 objectives :
1. Provide the EU academic, SME and industrial communities’ with access to world-class FT-ICR MS centers.
2. Build an EU community of end-users and FT-ICR MS scientists.
3.Open access to data and open source software to the EU FT-ICR MS network.
4. Strengthen the FT-ICR MS application fields by promoting innovative and cooperative research between European FT-ICR MS academic scientists and private companies(instrumentation and software).


European Network of Fourier-Transform Ion-Cyclotron-Resonance Mass Spectrometry Centers
Molecular signatures of normal and aberrant development, aging and longevity in human brain
Comprehensive characterization of CRISPR-linked genes
Interpretable model for chromatin interaction probability prediction